| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 498.70M | 593.10M | 656.50M | 663.60M | 667.20M |
| Gross Profit | 146.20M | 167.00M | 206.40M | 219.50M | 220.50M |
| EBITDA | -12.60M | -9.30M | 34.40M | 64.70M | 50.00M |
| Net Income | -81.90M | -25.00M | 7.70M | 33.60M | 24.40M |
Balance Sheet | |||||
| Total Assets | 354.70M | 397.70M | 462.30M | 435.40M | 472.50M |
| Cash, Cash Equivalents and Short-Term Investments | 26.10M | 12.00M | 21.10M | 2.10M | 61.20M |
| Total Debt | 125.70M | 62.30M | 94.10M | 38.00M | 43.50M |
| Total Liabilities | 244.70M | 206.70M | 241.90M | 210.60M | 240.40M |
| Stockholders Equity | 110.00M | 191.00M | 220.40M | 224.80M | 232.10M |
Cash Flow | |||||
| Free Cash Flow | -49.60M | -3.00M | -5.70M | -2.90M | 6.90M |
| Operating Cash Flow | -45.20M | 7.60M | 12.50M | 10.90M | 13.80M |
| Investing Cash Flow | 16.60M | 50.70M | -13.40M | -12.10M | 9.30M |
| Financing Cash Flow | 45.20M | -67.70M | 19.30M | -58.20M | -22.10M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | £56.56M | 3.42 | 20.89% | 0.55% | 2.64% | 23.89% | |
72 Outperform | £4.42B | 16.92 | 23.58% | 2.57% | 0.13% | -0.06% | |
68 Neutral | £37.80M | 6.55 | 8.41% | 11.65% | -3.45% | -44.02% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
56 Neutral | £299.25M | 4.43 | 13.23% | ― | 4.38% | ― | |
49 Neutral | £40.47M | 9.31 | -22.13% | 3.45% | -4.23% | -435.86% | |
42 Neutral | £24.64M | -0.46 | -61.90% | ― | -11.65% | -273.57% |